Neuroprotective Activity of Some Marine Fungal Metabolites in the 6-Hydroxydopamin- and Paraquat-Induced Parkinson’s Disease Models

Marine Drugs
2018.0

Abstract

<jats:p>A new melatonin analogue 6-hydroxy-N-acetyl-β-oxotryptamine (1) was isolated from the marine-derived fungus Penicillium sp. KMM 4672. It is the second case of melatonin-related compounds isolation from microfilamentous fungi. The neuroprotective activities of this metabolite, as well as 3-methylorsellinic acid (2) and 8-methoxy-3,5-dimethylisochroman-6-ol (3) from Penicillium sp. KMM 4672, candidusin A (4) and 4″-dehydroxycandidusin A (5) from Aspergillus sp. KMM 4676, and diketopiperazine mactanamide (6) from Aspergillus flocculosus, were investigated in the 6-hydroxydopamine (6-OHDA)- and paraquat (PQ)-induced Parkinson’s disease (PD) cell models. All of them protected Neuro2a cells against the damaging influence of 6-OHDA to varying degrees. This effect may be realized via a reactive oxygen species (ROS) scavenging pathway. The new melatonin analogue more effectively protected Neuro2A cells against the 6-OHDA-induced neuronal death, in comparison with melatonin, as well as against the PQ-induced neurotoxicity. Dehydroxylation at C-3″ and C-4″ significantly increased free radical scavenging and neuroprotective activity of candidusin-related p-terphenyl polyketides in both the 6-OHDA- and PQ-induced PD models.

Knowledge Graph

Similar Paper

Neuroprotective Activity of Some Marine Fungal Metabolites in the 6-Hydroxydopamin- and Paraquat-Induced Parkinson’s Disease Models
Marine Drugs 2018.0
Solid‐state‐cultured mycelium of Antrodia camphorata exerts potential neuroprotective activities against 6‐hydroxydopamine‐induced toxicity in <scp>PC12</scp> cells
Journal of Food Biochemistry 2022.0
Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage
Bioorganic &amp; Medicinal Chemistry 2016.0
Marine-Derived Components: Can They Be a Potential Therapeutic Approach to Parkinson’s Disease?
Marine Drugs 2023.0
Synthesis of a natural quinoline alkaloid isolated from the deep-sea-derived fungus and its potential as a therapeutic for Parkinson’s disease
Journal of Asian Natural Products Research 2023.0
Tetramic acid-motif natural products from a marine fungus Tolypocladium cylindrosporum FB06 and their anti-Parkinson activities
Marine Life Science &amp; Technology 2023.0
Anti-neuroinflammatory effect of oxaline, isorhodoptilometrin, and 5-hydroxy-7-(2′-hydroxypropyl)-2-methyl-chromone obtained from the marine fungal strain Penicillium oxalicum CLC-MF05
Archives of Pharmacal Research 2022.0
New Anti-Hypoxic Metabolites from Co-Culture of Marine-Derived Fungi Aspergillus carneus KMM 4638 and Amphichorda sp. KMM 4639
Biomolecules 2023.0
Synthesis and biological evaluation of novel marine-derived indole-based 1,2,4-oxadiazoles derivatives as multifunctional neuroprotective agents
Bioorganic &amp; Medicinal Chemistry Letters 2015.0
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease
CNS &amp; Neurological Disorders - Drug Targets 2023.0